Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Interventions: DRUG: onapristone
Sponsor: Arno Therapeutics